radioembolization in the treatment of neuroendocrine tumor metastases to the liver
Clicks: 218
ID: 181139
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
218 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #7 of 25 articles by views in harbin gongye daxue xuebao/journal of harbin institute of technology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Surgical excision remains the preferred treatment for resectable hepatic metastases of
neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial
radioembolization with Yttrium-90- (90Y-) labeled microspheres has been demonstrated as a
viable option for symptom and locoregional tumor control. On an outpatient basis,
radioembolization can be utilized from early line to salvage phases, in various combinations with
systemic therapies. Review of available data shows encouraging safety and efficacy profiles for
the intraarterial application of 90Y for the treatment of mNETs of the liver. Symptom control and
decrease in somatostatin analog use can be achieved, as well as prolonged survival.
| Reference Key |
vyleta2011internationalradioembolization
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Martin Vyleta;Douglas Coldwell |
| Journal | harbin gongye daxue xuebao/journal of harbin institute of technology |
| Year | 2011 |
| DOI |
10.4061/2011/785315
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.